Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes.
Saved in:
| Title: | Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes. |
|---|---|
| Authors: | Adinolfi LE; Department of Advanced Medical and Surgical Sciences, School of Medicine, Internal Medicine, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy., Marrone A; Department of Advanced Medical and Surgical Sciences, School of Medicine, Internal Medicine, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy., Izzi A; Department of Infectious Diseases, D. Cotugno Hospital, 80138 Napoli, Italy., Craxì A; PROMISE, School of Medicine, Gastroenterology and Hepatology, University of Palermo, Palermo, Italy. |
| Source: | Journal of clinical and experimental hepatology [J Clin Exp Hepatol] 2026 Jan-Feb; Vol. 16 (1), pp. 103411. Date of Electronic Publication: 2025 Nov 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: India NLM ID: 101574137 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0973-6883 (Print) Linking ISSN: 09736883 NLM ISO Abbreviation: J Clin Exp Hepatol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
